Applied Biosystems has expanded its line of labelling chemistry reagents which are used for proteomics research in academic and biopharmaceutical laboratories aiming to double the existing capacity for discovering proteins and comparing protein levels between biological samples that support biomarker discovery.

Applied Biosystems has expanded its line of labelling chemistry reagents which are used for proteomics research in academic and biopharmaceutical laboratories. The addition has come in the form of the company’s new 8plex version of iTRAQ®. The reagents are designed with the aim of doubling the existing capacity for discovering proteins and comparing protein levels between biological samples that support biomarker discovery.

The increased capacity brought about by the new iTRAQ reagents aids the researchers with the ability to obtain higher throughput and more efficiency in conducting their biomarker discovery when compared to the label-free methods or other approaches using reagents with more limited multiplexing capacity. The discovery of biomarkers to better understand diseases requires large numbers of sample sets on precise experimental systems. With the new reagents for simultaneous comparison or multiplexing of samples, experiments that might otherwise take months with other methods can be completed with better accuracy in a matter of days or weeks. The new reagents are intended to make the process of biomarker discovery more productive and to increase the scale of experiments conducted by research laboratories.